Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial.

Klaus F. Rabe,Fernando J. Martinez,Dave Singh,Roopa Trivedi,Martin Jenkins,Patrick Darken,Magnus Aurivillius,Paul Dorinsky

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial.

2021

Klaus F. Rabe
Fernando J. Martinez
Dave Singh
Roopa Trivedi
Martin Jenkins
Patrick Darken
Magnus Aurivillius
Paul Dorinsky

Background:In the phase III, 52-week ETHOS study in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), triple therapy with budesonide/glycopyrrolate/formoterol fuma...

Keywords:

Formoterol Fumarate
Internal medicine
Metered-dose inhaler
Pulmonary function testing
in patient
Glycopyrrolate
Budesonide
Medicine
Formoterol
COPD

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations